Covid-19 virus may spread more widely by turning lung cells into targets, study finds
Sign up now: Get ST's newsletters delivered to your inbox
A study suggests that Covid-19 spreads by making more lung cells vulnerable, driving severe inflammation and damage.
PHOTO: ST FILE
DeeperDive is a beta AI feature. Refer to full articles for the facts.
NEW YORK – The coronavirus that causes Covid-19 may spread through the lungs by turning previously resistant cells into targets for infection, a finding that helps explain the widespread inflammation and organ damage seen in severe cases and points to a potential new treatment.
Lung cells release tiny particles that carry the key proteins the virus uses to enter cells, researchers at the Icahn School of Medicine at Mount Sinai in New York found.
When those particles are taken up by other cells, including immune and blood vessel cells, they can make them newly vulnerable to infection, according to a study published on April 10 in Nature Communications.
That process could help explain a longstanding puzzle in Covid-19: how the virus affects a wide range of tissues, even those that do not appear to produce the necessary entry proteins on their own.
Damage to blood vessels and immune cells has been linked to complications, including clotting, inflammation and multi-organ failure in severe cases.
The particles, known as extracellular vesicles, appear to act as delivery vehicles for the proteins, effectively expanding the number of cells the virus can infect.
In laboratory models, cells exposed to these vesicles were more susceptible to infection, while blocking key components reduced viral spread.
The findings add to growing evidence that the body’s own cell-to-cell communication systems may help viruses propagate once infection takes hold, revealing a previously unrecognised route of infection that could extend beyond Covid-19.
While the research was conducted in lab-grown lung models rather than patients, it highlights a potential new strategy for treatment: targeting the transfer of these proteins between cells.
Drugs that interfere with that process could help limit how far the virus spreads within the body and reduce the severity of disease.
Further research is needed to determine how important this pathway is in patients and whether it can be safely disrupted.
Still, the findings point to potential new ways to treat Covid-19 and other viral infections, Dr Ya-Wen Chen and colleagues wrote. BLOOMBERG
